Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Non-cash Items (2016 - 2024)

Historic Non-cash Items for Assembly Biosciences (ASMB) over the last 8 years, with Q4 2024 value amounting to $517237.0.

  • Assembly Biosciences' Non-cash Items rose 5162370.0% to $517237.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $517237.0, marking a year-over-year increase of 5162370.0%. This contributed to the annual value of $517237.0 for FY2024, which is 5162370.0% up from last year.
  • According to the latest figures from Q4 2024, Assembly Biosciences' Non-cash Items is $517237.0, which was up 5162370.0% from $1000.0 recorded in Q4 2023.
  • Assembly Biosciences' Non-cash Items' 5-year high stood at $21.5 million during Q1 2020, with a 5-year trough of $1000.0 in Q3 2022.
  • Over the past 5 years, Assembly Biosciences' median Non-cash Items value was $774000.0 (recorded in 2021), while the average stood at $2.9 million.
  • In the last 5 years, Assembly Biosciences' Non-cash Items plummeted by 9997.35% in 2022 and then surged by 5162370.0% in 2024.
  • Quarter analysis of 5 years shows Assembly Biosciences' Non-cash Items stood at $1.9 million in 2020, then crashed by 97.14% to $53000.0 in 2021, then tumbled by 98.11% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then surged by 51623.7% to $517237.0 in 2024.
  • Its Non-cash Items stands at $517237.0 for Q4 2024, versus $1000.0 for Q4 2023 and $1000.0 for Q3 2022.